Results 31 to 40 of about 13,789 (225)
Scientific Reports, 2017 Biventricular pacing is an important modality to improve left ventricular (LV) synchronization and long-term function. However, the biological effects of this treatment are far from being elucidated and existing animal models are limited and demanding ...
Wesam Mulla +9 more
doaj +1 more source
Is there a utility for QRS dispersion in clinical practice? [PDF]
, 2017 Prognostic markers derived from standard ECG have always been seductive. Increased dispersion of durations of the P wave, of the QRS complex, or of the QT interval has been associated with the risk of atrial fibrillation, ventricular arrhythmias, sudden ...
Chávez-González, Elibet +2 more
core +8 more sources
TEE-guided left ventricular epicardial pacing lead placement for cardiac resynchronization therapy
Annals of Cardiac Anaesthesia, 2012 Biventricular pacing has demonstrated improvement in cardiac functions in treating congestive cardiac failure patients. Recent trials have proven the clinical and functional benefits of cardiac resynchronization therapy in severe heart failure and ...
Rajesh Chand Arya +3 more
doaj +1 more source
Biventricular Pacing in Normal Hearts
Reviews in Cardiovascular Medicine, 2012 For more than half a century, pacemakers have proven to be one of the most successful medical interventions. In an effort to approximate normal cardiac physiology, pacemakers have evolved from simple to highly sophisticated devices. There is a growing demand, not only to improve overall mortality and safety in patients with ...
Tariq, Bhat +5 more
openaire +2 more sources
Frontiers in Cardiovascular Medicine, 2023 Conduction system pacing (CSP) has been emerging over the last decade as a pacing option instead of conventional right ventricular (RV) pacing and biventricular (BiV) pacing.
Ahmed T. Moustafa +2 more
doaj +1 more source
The relation between cardiac 123I-mIBG scintigraphy and functional response 1 year after CRT implantation [PDF]
, 2020 Cardiac resynchronization therapy (CRT) is a disease-modifying therapy in patients with chronic heart failure (CHF). Current guidelines ascribe CRT eligibility on three parameters only: left ventricular ejection fraction (LVEF), QRS duration, and New ...
de Groot, J R +7 more
core +1 more source
Biventricular pacing in heart failure: update on results from clinical trials
Current Controlled Trials in Cardiovascular Medicine, 2001 Biventricular pacing or resynchronisation therapy is a non-pharmacological therapy for patients with chronic heart failure. Since being originally described in 1994, biventricular pacing has become a subject of intense interest and investigation.
Haywood Guy
doaj +1 more source
Reduction of Hospital Days by Biventricular Pacing [PDF]
European Journal of Heart Failure, 2000 Abstract The health care costs for heart failure are substantial. Studies indicate that hospital treatment constitutes 65–75% of these. The aim of this study was to assess total and heart failure related hospital days as well as safety and efficacy of biventricular pacing in 16 patients with severe heart failure and delayed ...
F, Braunschweig +3 more
openaire +2 more sources
Indian Pacing and Electrophysiology Journal, 2016 Cardiac resynchronization therapy device (CRT-P and CRT-D) implantation has increased tremendously with increasing operator experience, eligible patients and expansion of indications.
Soumen Devidutta +2 more
doaj +1 more source
Techniques for Identification of Left Ventricular Asynchrony for Cardiac Resynchronization Therapy in Heart Failure [PDF]
, 2005 The most recent treatment option of medically refractory heart failure includes cardiac resynchronization therapy (CRT) by biventricular pacing in selected patients in NYHA functional class III or IV heart failure. The widely used marker to indicate left
Peter, Schuster, Svein, Faerestrand
core